LIEN
Price
$10.88
Change
+$0.11 (+1.02%)
Updated
Sep 8, 01:07 PM (EDT)
Capitalization
245.78M
59 days until earnings call
SHPH
Price
$3.33
Change
-$0.04 (-1.19%)
Updated
Sep 8, 01:11 PM (EDT)
Capitalization
3.61M
Interact to see
Advertisement

LIEN vs SHPH

Header iconLIEN vs SHPH Comparison
Open Charts LIEN vs SHPHBanner chart's image
Chicago Atlantic BDC
Price$10.88
Change+$0.11 (+1.02%)
Volume$200
Capitalization245.78M
Shuttle Pharmaceuticals Holdings
Price$3.33
Change-$0.04 (-1.19%)
Volume$200
Capitalization3.61M
LIEN vs SHPH Comparison Chart in %
Loading...
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIEN vs. SHPH commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIEN is a Hold and SHPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (LIEN: $10.77 vs. SHPH: $3.37)
Brand notoriety: LIEN and SHPH are both not notable
LIEN represents the Investment Managers, while SHPH is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LIEN: 46% vs. SHPH: 16%
Market capitalization -- LIEN: $245.78M vs. SHPH: $3.61M
LIEN [@Investment Managers] is valued at $245.78M. SHPH’s [@Pharmaceuticals: Generic] market capitalization is $3.61M. The market cap for tickers in the [@Investment Managers] industry ranges from $170.21B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Investment Managers] industry is $7.56B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIEN’s FA Score shows that 1 FA rating(s) are green whileSHPH’s FA Score has 0 green FA rating(s).

  • LIEN’s FA Score: 1 green, 4 red.
  • SHPH’s FA Score: 0 green, 5 red.
According to our system of comparison, LIEN is a better buy in the long-term than SHPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIEN’s TA Score shows that 3 TA indicator(s) are bullish while SHPH’s TA Score has 3 bullish TA indicator(s).

  • LIEN’s TA Score: 3 bullish, 6 bearish.
  • SHPH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SHPH is a better buy in the short-term than LIEN.

Price Growth

LIEN (@Investment Managers) experienced а -2.18% price change this week, while SHPH (@Pharmaceuticals: Generic) price change was +2.12% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -0.26%. For the same industry, the average monthly price growth was +2.60%, and the average quarterly price growth was +44.82%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.00%, and the average quarterly price growth was +87.12%.

Reported Earning Dates

LIEN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Investment Managers (-0.26% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIEN($246M) has a higher market cap than SHPH($3.61M). LIEN YTD gains are higher at: -6.118 vs. SHPH (-84.307). SHPH has more cash in the bank: 4.82M vs. LIEN (5.4K). SHPH has less debt than LIEN: SHPH (713K) vs LIEN (5M). LIEN has higher revenues than SHPH: LIEN (31.4M) vs SHPH (0).
LIENSHPHLIEN / SHPH
Capitalization246M3.61M6,816%
EBITDAN/A-11.67M-
Gain YTD-6.118-84.3077%
P/E Ratio7.98N/A-
Revenue31.4M0-
Total Cash5.4K4.82M0%
Total Debt5M713K701%
TECHNICAL ANALYSIS
Technical Analysis
LIENSHPH
RSI
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
36%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
50%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
58%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCMWY74.451.57
+2.16%
Swisscom AG
HSHZY9.00N/A
N/A
Hoshizaki Corporation
HUBV0.11N/A
N/A
Hubb Ventures Inc.
SNCPF43.00N/A
N/A
Sun Corp.
ACHFF1.15-0.03
-2.21%
Arch Biopartners Inc.

LIEN and

Correlation & Price change

A.I.dvisor tells us that LIEN and SHPH have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIEN and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
-0.87%
SHPH - LIEN
20%
Poorly correlated
-1.17%
IMCC - LIEN
13%
Poorly correlated
-3.90%
BAM - LIEN
10%
Poorly correlated
-1.25%
ECCF - LIEN
10%
Poorly correlated
-0.43%
RWAY - LIEN
8%
Poorly correlated
-0.19%
More

SHPH and

Correlation & Price change

A.I.dvisor tells us that SHPH and LFCR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPH and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPH
1D Price
Change %
SHPH100%
-1.17%
LFCR - SHPH
31%
Poorly correlated
-5.16%
PLSH - SHPH
24%
Poorly correlated
-18.28%
IPSEF - SHPH
20%
Poorly correlated
N/A
LIEN - SHPH
20%
Poorly correlated
-0.87%
BFRI - SHPH
10%
Poorly correlated
+0.64%
More